News
Also: OptimizeRx's new platform consolidates its acquisitions; Weather Channel app launches machine learning flu risk predictor.
All of the life insurer’s members with Type 1 or Type 2 diabetes will have access to the service, which offers savings on premiums.
Also: OptimizeRx's new platform consolidates its acquisitions; Weather Channel app launches machine learning flu risk predictor.
Modus Capital led the round with participation from 212 Capital, QSTP, Kasamar Holdings, Dharmendra Ghai, Innoway and other unnamed investors.
This year, 42% of survey-takers reported using at least one digital health tracking tool.
The Utah-based company's platform helps small to medium-sized practices manage their patient communications.
First Trust Capital Partners led the round with participation from Sumitomo Corporation of Americas and Ziegler.
Cognoa and MedRhythms will be kicking off multi-site investigations of their tools, which are designed for pediatric autism diagnosis and stroke rehabilitation, respectively.
Aflac Corporate Ventures led the round with participation from NMC, Nippon Life Insurance Company, Susquehanna International Group, Sojitz Corporation, Zuellig Pharma and Silicon Valley Bank.